bioRxiv/medRxiv TRiP Review Activity

438 Reviews — All Partners — Cancer Biology

Most recent first Previous |  Page 11: Articles 101-110  | Next

STAMBPL1 activates the GRHL3/HIF1A/VEGFA axis through interaction with FOXO1 to promote angiogenesis in triple-negative breast cancer
Fang, H., Liang, H., Yang, C., Jiang, D., Luo, Q., Cao, W., Zhang, H., Chen, C.
10.1101/2024.08.31.610659 — Posted: 2024-09-01 — Discussion: 2025-02-27  eLife
Propionyl-CoA carboxylase subunit B modulates PIK3CA-regulated immune-surveillance in a pancreatic cancer mouse model
Han, H. V., Efem, R., Rosati, B., Maimouni, S., Lu, K., Jiang, Y.-P., Zong, W.-X., Lin, R. Z.
10.1101/2023.07.24.550301 — Posted: 2023-07-26 — Discussion: 2025-02-24  eLife
Tks5 interactome reveals ER-associated machinery translation in invadosomes.
NORMAND, L., BONNARD, B., Sala, M., DI-TOMMASO, S., DOURTHE, C., RAYMOND, A.-A., DUPUY, J.-W., MERCIER, L., GOETZ, J. G., MOREAU, V., HENRIET, E., SALTEL, F.
10.1101/2024.07.02.601728 — Posted: 2024-07-04 — Discussion: 2025-02-24  Review Commons
Loss of ZNRF3/RNF43 Unleashes EGFR in Cancer
Yue, F., Ku, A. T., Stevens, P., Michalski, M., Jiang, W., Tu, J., Shi, Z., Dou, Y., Wang, Y., Feng, X.-H., Hostetter, G., Wu, X., Huang, S., Shroyer, N., Zhang, B., Williams, B., Liu, Q., Lin, X., Li, Y.
10.1101/2024.01.10.574969 — Posted: 2024-01-11 — Discussion: 2025-02-17  eLife
Deuterium Metabolic Imaging Phenotypes Mouse Glioblastoma Heterogeneity Through Glucose Turnover Kinetics
Simoes, R. V., Henriques, R. N., Olesen, J. L., Cardoso, B. M., Fernandes, F. F., Monteiro, M. A., Jespersen, S., Carvalho, T., Shemesh, N.
10.1101/2024.06.23.600246 — Posted: 2024-06-29 — Discussion: 2025-01-30  eLife
NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in Solitary Fibrous Tumors
Hill, C., Indeglia, A., Picone, F., Murphy, M., Cipriano, C., Maki, R. G., Gardini, A.
10.1101/2024.04.15.589533 — Posted: 2024-04-20 — Discussion: 2025-01-30  eLife
Combinatorial CRISPR screen reveals FYN and KDM4 as targets for synergistic drug combination for treating triple negative breast cancer
Kim, T., Park, B.-S., Heo, S., Jeon, H., Kim, J., Kim, D., Kook Lee, S., Jung, S.-Y., Kong, S.-Y., Lu, T.
10.1101/2023.11.08.566220 — Posted: 2023-11-08 — Discussion: 2025-01-29  eLife
Plectin-mediated cytoskeletal crosstalk as a target for inhibition of hepatocellular carcinoma growth and metastasis.
Korelova, K., Prechova, M., Frick, L., Sarnova, L., Bisht, P., Novotna, P., Kosla, J., Bortel, P., Borutzki, Y., Bileck, A., Gerner, C., Rahbari, M., Rahbari, N., Birgin, E., Kvasnicova, B., Galisova, A., Sulkova, K., Bauer, A., Jobe, N., Tolde, O., Sticova, E., Rosel, D., O Connor, T., Otahal, M., Jirak, D., Heikenwalder, M., Wiche, G., Meier-Menches, S. M., Gregor, M.
10.1101/2024.08.02.606331 — Posted: 2024-08-06 — Discussion: 2025-01-27  eLife
Non-destructive in situ monitoring of structural changes of 3D tumor spheroids during the formation, migration, and fusion process
Ning, K., Xie, Y., Sun, W., Feng, L., Fang, C., Pan, R., Li, Y., Yu, L.
10.1101/2024.07.25.605064 — Posted: 2024-07-25 — Discussion: 2025-01-23  eLife
Mapping kinase domain resistance mechanisms for the MET receptor tyrosine kinase via deep mutational scanning
Estevam, G. O., Linossi, E. M., Rao, J., Macdonald, C. B., Ravikumar, A., Chrispens, K. M., Capra, J. A., Coyote-Maestas, W., Pimentel, H., Collisson, E. A., Jura, N., Fraser, J. S.
10.1101/2024.07.16.603579 — Posted: 2024-07-18 — Discussion: 2025-01-23  eLife

Evaluation Sources